SALVESTRINI, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 2.564
AS - Asia 2.220
EU - Europa 1.489
AF - Africa 131
SA - Sud America 103
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.514
Nazione #
US - Stati Uniti d'America 2.529
VN - Vietnam 764
SG - Singapore 537
CN - Cina 482
GB - Regno Unito 368
SE - Svezia 213
IT - Italia 198
DE - Germania 185
HK - Hong Kong 113
IN - India 103
FR - Francia 94
BR - Brasile 70
NL - Olanda 68
UA - Ucraina 67
RU - Federazione Russa 64
IE - Irlanda 51
KR - Corea 48
CI - Costa d'Avorio 36
BG - Bulgaria 32
JP - Giappone 32
ZA - Sudafrica 30
TG - Togo 28
EE - Estonia 27
FI - Finlandia 27
CA - Canada 25
BE - Belgio 23
JO - Giordania 22
TH - Thailandia 22
CH - Svizzera 15
ID - Indonesia 14
SC - Seychelles 14
PL - Polonia 13
AR - Argentina 11
AT - Austria 11
ES - Italia 11
IQ - Iraq 11
PH - Filippine 11
TR - Turchia 10
EG - Egitto 8
BD - Bangladesh 7
IR - Iran 7
MX - Messico 7
TW - Taiwan 7
EC - Ecuador 6
NG - Nigeria 6
MY - Malesia 5
PK - Pakistan 5
SA - Arabia Saudita 5
AU - Australia 4
CL - Cile 4
PT - Portogallo 4
RO - Romania 4
UZ - Uzbekistan 4
PE - Perù 3
UY - Uruguay 3
CO - Colombia 2
CZ - Repubblica Ceca 2
GR - Grecia 2
HR - Croazia 2
KE - Kenya 2
KG - Kirghizistan 2
LB - Libano 2
LT - Lituania 2
MA - Marocco 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PY - Paraguay 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EU - Europa 1
HU - Ungheria 1
JM - Giamaica 1
KZ - Kazakistan 1
MD - Moldavia 1
MM - Myanmar 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TN - Tunisia 1
Totale 6.514
Città #
Singapore 385
Southend 311
Ashburn 280
Fairfield 277
Chandler 257
Ho Chi Minh City 185
Hanoi 173
San Jose 152
Ann Arbor 123
Woodbridge 121
Wilmington 113
Seattle 111
Hong Kong 105
Houston 100
Hefei 91
Cambridge 89
Santa Clara 84
Princeton 67
Beijing 60
Dong Ket 56
Dublin 51
Boardman 47
Bologna 41
Seoul 41
Abidjan 36
Jacksonville 35
Lauterbourg 35
Los Angeles 32
Sofia 32
Nanjing 29
Haiphong 28
Lomé 28
Tokyo 28
Westminster 28
Padova 27
Hyderabad 25
Da Nang 24
Brussels 23
New York 23
Amman 22
Berlin 20
Council Bluffs 20
Buffalo 19
Frankfurt am Main 19
Shenyang 19
Dallas 18
Helsinki 18
San Diego 16
Milan 15
Bern 14
Bremen 12
Jinan 12
Biên Hòa 11
London 11
Redondo Beach 11
Saint Petersburg 11
Bangkok 10
Hải Dương 10
Munich 10
Turin 10
Hebei 9
Ninh Bình 9
Tianjin 9
Toronto 9
Amsterdam 8
Jakarta 8
Quận Bình Thạnh 8
Redwood City 8
Bengaluru 7
Changsha 7
Des Moines 7
Guangzhou 7
Hangzhou 7
Jiaxing 7
Orem 7
Shanghai 7
Stockholm 7
São Paulo 7
Warsaw 7
Chicago 6
Falkenstein 6
Ha Long 6
Haikou 6
Mülheim 6
Vienna 6
Wuhan 6
Yubileyny 6
Zhengzhou 6
Abeokuta 5
Baghdad 5
Boston 5
Cairo 5
Chennai 5
Cosenza 5
Hamm 5
Kunming 5
Lappeenranta 5
Mahé 5
Ningbo 5
Nuremberg 5
Totale 4.320
Nome #
IL-18 and VEGF-A trigger type 2 innate lymphoid cell accumulation and pro-tumoral function in chronic myeloid leukemia 343
CD103 marks a subset of human CD34+-derived langerin+ dendritic cells that induce T-regulatory cells via indoleamine 2,3-dioxygenase-1 256
Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2,3-dioxygenase. 250
ATP release from chemotherapy-treated dying leukemia cells Elicits an immune suppressive effect by increasing regulatory T cells and Tolerogenic dendritic cells 225
Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells. 220
Immunosenescence and immunotherapy in elderly acute myeloid leukemia patients: Time for a biology-driven approach 212
Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34- cell population with intrinsic resistance to imatinib. 203
The Human Mesenchymal Stromal Cell-Derived Osteocyte Capacity to Modulate Dendritic Cell Functions Is Strictly Dependent on the Culture System 196
The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration. 195
The more, the better: "Do the right thing" for natural killer immunotherapy in acute myeloid leukemia 195
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis 194
Gut Microbiome as a Potential Marker of Hematologic Recovery Following Induction Therapy in Acute Myeloid Leukemia Patients 192
Differential proteomic profile of leukemic CD34+ progenitor cells from chronic myeloid leukemia patients 188
The SOCS3-independent expression of IDO2 supports the homeostatic generation of T regulatory cells by human dendritic cells. 186
Extracellular ATP induces apoptosis through P2X7R activation in acute myeloid leukemia cells but not in normal hematopoietic stem cells 185
PGE2-induced IDO1 inhibits the capacity of fully mature DCs to elicit an in vitro antileukemic immune response 184
Denatonium as a Bitter Taste Receptor Agonist Modifies Transcriptomic Profile and Functions of Acute Myeloid Leukemia Cells 184
The role of the immunosuppressive microenvironment in acute myeloid leukemia development and treatment. 183
Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells 182
Phospholipase C beta1 (PI-PLCbeta1)/Cyclin D3/protein kinase C (PKC) alpha signaling modulation during iron-induced oxidative stress in myelodysplastic syndromes (MDS) 182
The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling 181
Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells. 180
Extracellular ATP exerts opposite effects on activated and regulatory CD4 + T cells via purinergic P2 receptor activation 178
Corrigendum: Denatonium as a Bitter Taste Receptor Agonist Modifies Transcriptomic Profile and Functions of Acute Myeloid Leukemia Cells (Front. Oncol, (2020), 10, (1225), 10.3389/fonc.2020.01225) 178
The tissue inhibitor of metalloproteinases 1 increases the clonogenic efficiency of human hematopoietic progenitor cells through CD63/PI3K/Akt signaling 170
Extracellular purines promote the differentiation of human bone marrow-derived mesenchymal stem cells to the osteogenic and adipogenic lineages. 168
The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology. 167
Purinergic stimulation of human mesenchymal stem cells potentiates their chemotactic response to CXCL12 and increases the homing capacity and production of proinflammatory cytokines. 165
Ex vivo characterization of acute myeloid leukemia patients undergoing hypomethylating agents and venetoclax regimen reveals a venetoclax-specific effect on non-suppressive regulatory T cells and bona fide PD-1+TIM3+ exhausted CD8+ T cells 162
Purinergic signaling inhibits human acute myeloblastic leukemia cell proliferation, migration, and engraftment in immunodeficient mice. 159
Zinc-finger transcription factor slug contributes to the survival advantage of chronic myeloid leukemia cells. 155
Obesity may accelerate the aging process 155
Bitter Taste Receptor Agonist Denatonium Inhibits Stemness Characteristics in Hematopoietic Stem/Progenitor Cells 151
The Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) Regulates the Function and Migration of Leukemic Blasts through CD63/PI3K/AKT/P21 Axis 134
The sixth sense: Hematopoietic Stem Cells detect danger through purinergic signalling. 123
Noncanonical NF-κB signaling in dendritic cells is required for ATP-driven indoleamine 2,3-dioxygenase 1 induction through P2Y11 receptor 39
Totale 6.620
Categoria #
all - tutte 16.004
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.004


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021165 0 0 0 0 0 0 0 0 0 26 19 120
2021/2022743 62 31 50 55 62 33 18 37 32 53 158 152
2022/2023794 114 137 43 118 43 64 23 33 121 12 43 43
2023/2024197 17 21 10 36 14 52 13 2 7 10 8 7
2024/2025857 49 109 54 88 128 43 41 32 26 85 49 153
2025/20262.270 398 173 169 190 212 119 211 113 532 153 0 0
Totale 6.620